Summary
Background: Despite the numerous treatment modalities available for vitiligo, responses to treatment are still unsatisfactory. For this reason, new treatment modalities and approaches are needed.
Objective: To evaluate the efficacy and safety of fractional carbon dioxide (CO 2 ) laser therapy followed by narrow band ultraviolet-B (NB-UVB) phototherapy on stable resistant vitiligo.
Subjects and methods: Thirty-two patients with stable bilateral vitiligo were enrolled. For each patient, one side of the body was treated with NB-UVB in addition to two sessions of fractional CO 2 laser performed at 2-months interval (laser side), while the other side was treated with NB-UVB alone (control side). NB-UVB was administrated twice weekly for 4 months. Outcomes were evaluated objectively based on standard digital photographs, patient satisfaction, and adverse effects.
Results: There was statistically significant improvement in the repigmentation in laser side compared to control side. Noticeable adverse events, such as infection, scarring, and Koebner phenomenon were not found in any patient.
Conclusions: Fractional CO 2 laser therapy combined with NB-UVB phototherapy could be used effectively and safely as an alternative modality for the treatment of vitiligo. It shortens the duration of NB-UVB therapy and is expected to increase patient compliance
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| INTRODUCTION
Vitiligo is an autoimmune disorder of melanocyte characterized by circumscribed depigmented macules which can occur at any site of the skin over both hairy and glabrous areas. 1 According to distribution, vitiligo can be clinically classified into focal, acrofacial, segmen- Patients were also excluded if they received any topical medications, phototherapy, or laser for vitiligo within 1 month prior to enrollment.
Pregnant and lactating females, young patients under 18 years, and patients with unrealistic expectation were not included in this study.
| Treatment procedure
For each patient, one side of the body was treated with NB-UVB alone (control side), while the other side was treated with NB-UVB therapy in addition to fractional CO 2 laser (laser side). Treatment side was randomly chosen to ensure blindness of clinical assessment.
Each patient signed a written consent form to be included in this study and to be photographed.
| The NB-UVB therapy
All patients received NB-UVB sessions on both side of the body 3 times per week for a maximum of 4 months or when complete repigmentation was achieved. The NB-UVB source was eight NB fluorescent tubes (Philips TL 100, Hamburg, Germany) with a spectrum of 310-315 nm and a maximum wave length of 311 nm installed in a Waldmann UV-100 unit. The initial dose of UVB was 0. The planned treated area of the laser side was subjected to two sessions of fractional CO 2 laser two months apart followed by NB-UVB phototherapy as follows:
Local anesthetic cream was applied under occlusion for 30-40 minutes before starting the laser. The laser used is fractional CO 2 laser (Microxel MX7000, Daeshin Enterprise, Korea). Two passes were delivered using pulse energy of 30 mj, density level of 5 dots, and depth level of 5. Cooling is not used. A 2-mm rim of normal skin was included in laser session therapy. There was no premedication except for antiviral treatment (Valacyclovir 500 mg twice daily for 5 days). After the first laser treatment session, only antibiotic ointment was applied to the wound without any dressing for 5 days.
Then NB-UVB was applied to the planned treated area twice weekly for 2 months. After that, second laser session was performed, followed by phototherapy according to the same protocol.
2.3 | Assessment of the efficacy of the therapeutic procedure:
| Clinical assessment
Photographs were taken at baseline, monthly for 4 months, and 3 months after the final treatment using 16-mega pixel camera (Fujifilm camera, Japan).
Two dermatologists were asked to record percentage of improvement for each patient after completion of the treatment by comparing before and after digital photographs. The repigmentation response was expressed qualitatively as follows: excellent: >75%-100%, good: >50%-75%, moderate: >25%-50% and mild: <25%.
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Quantitative evaluation of the response was also performed in a numerical percentage for precise statistical evaluation.
The patients were asked at final visit to rate the overall satisfaction according to whether patient was not satisfied <25%, slightly satisfied 25%-<50%, satisfied 50% to <75%, or very satisfied >75%.
| Safety assessment
The patients were informed to report any complication occurred; erythema, pain, infection, postinflammatory hyperpigmentation, or any allergic manifestation, etc. . ..
| Follow-up assessment
The patients were followed up monthly for 3 months after the end of the treatment sessions to detect any recurrence, complications, or worsening of the lesions.
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| Histopathological examination
Three-millimeter punch biopsy specimen was taken from the lesional sites before treatment, and another biopsy was taken from the same site after the end of treatment sessions from each side of 10 patients. The biopsy specimens were stained by hematoxylin and eosin (H&E) and special immunohistochemical stains using Melan-A, 11 to study histopathological changes in the end of the treatment sessions.
| Statistical analysis of the data
Data were fed to the computer and analyzed using IBM SPSS software package version 20.0. Qualitative data were described using number and percent. Quantitative data were described using range (minimum and maximum), mean, standard deviation, and medium.
Wilcoxon signed-rank test was used to compare between combination treatment and NB-UVB only. Significance of the obtained results was judged when P value ≤ .05. In laser side, eight patients (25%) showed excellent improvement, two patients (6.3%) showed good improvement, two patients (6.3%) showed moderate improvement, ten patients (31.3%) showed minimal improvement, and ten patients (31.3%) showed no improvement.
| RESULTS
In control side, no patients had excellent improvement, two patients showed good improvement, two patients showed moderate improvement, two patients showed minimal improvement, and 26 patients showed no improvement. The qualitative response was significantly increased in laser side than control side (Table 1, Figures 1, 2 and 3) .
Also, the quantitative response was significantly higher in laser side than control side in trunk and extremities. While in facial and acral parts, the improvement was better in laser side than control side but not significant (Table 2 , Figure 4 ).
| Regarding patients' satisfaction
In laser side, 10 patients (31.3%) were not satisfied, 10 patients (31.3%) were slightly satisfied, 4 patients (12.5%) were satisfied, and 8 patients (25.0%) were very satisfied. In control side, twenty-six patients (81.3%) were not satisfied, 4 patients (12.5%) were slightly satisfied, and 2 patients (6.3%) were satisfied. There was significant patients' satisfaction in laser side when compared to control side (P = .005) ( Table 3 ).
| Safety assessment
All patients experienced pain during the laser treatment, as well as burning sensation, and erythema and crustation after laser treatment.
However, the symptoms were relieved within a day and post-treatment crusting disappeared within a week. There were no patients with noticeable adverse events, such as infection, scaring, Koebner phenomenon, or aggravation of vitiligo.
| Follow-up assessment
After 3 months of follow-up, no relapses were reported in laser side, while in the control side, depigmentation restarted again in 25% of the patients. No Koebner phenomenon could be detected throughout the study from laser application. 
| Histopathological evaluation

| DISCUSSION
Westerhof and Neiuweboer-Krobotova in 1997 3 analyzed the outcome of NB-UVB therapy in vitiligo; they found that after 3 months, only 8% of patients showed a marked response compared to 63% after 1 year. The prolonged duration of NB-UVB therapy is the main reason for noncompliance, distance to be travelled and monetary, and time loss in attending the hospital at least twice a week for prolonged time were cited as the second common cause for attrition. 12 This clearly increases the need for combined therapy with NB-UVB to shorten the duration.
In recent years, the addition of laser treatment for vitiligo has been introduced. This includes ablative laser and fractional laser devices. According to previous studies, incorporating laser treatment to the conventional treatments of vitiligo such as topical therapy or phototherapy resulted in higher degree of repigmentation than conventional treatment alone 8, [13] [14] [15] [16] [17] In this study, we compared the efficacy of fractional CO 2 laser combined with NB-UVB phototherapy with UVB alone in the treatment of vitiligo. About 69% of the patients treated with combination of fractional carbon dioxide laser and NB-UVB showed minimal to excellent improvement. While 18.7% of the patients treated with NB-UVB alone showed minimal to good improvement. By comparing the degree of improvement between both groups, the difference was statistically significant (P value .007). This improvement was subjectively confirmed by the patients' satisfaction (P value .005).
According to the study by Shin et al., 8 two sessions of half-body fractional CO 2 laser therapy at a 2-month interval combined with twice weekly whole-body NB-UVB phototherapy result in significantly higher improvement rate compared to the contralateral side which did not receive fractional CO 2 laser treatment. Helou et al. 18 found that monthly sessions for 3 months of fractional CO In this study, with regard to body site, vitiligo of the trunk and extremities showed significant best results in laser side. In facial vitiligo, the improvement was better in laser side but we could not demonstrate a significant different between laser side and control side. Our results are confirmed by kanokrungsee et al, 19 who
reported that in facial vitiligo, the combined treatment with laser, targeted UVB, and topical steroids was not superior to targeted UVB and topical steroids in facial vitiligo. An explanation to this result is that facial location often yields good result to phototherapy and topical steroids. Therefore, laser treatment did not offer additional benefit compared to conventional treatment.
However, the acral parts showed poor response and hardly repigmented and statistically not significant than the control group, and this coincides with the previous studies. 7, 20 The acral parts and areas over bony prominence were difficult to repigment because few hair follicle density, which are the reservoir of melanocytes 21, 22 and also thick skin. However, Vachirman et al 14 demonstrated that combined ablative fractional CO 2 laser, NB-UVB, and 0.05% clobetasol propionate gave significantly higher mean improvement score than the combination of NB-UVB and 0.05% clobetasol propionate for the treatment of vitiligo in acral areas. This may be explained by the difference in protocol of treatment used in that study as every patient subjected to fractional CO 2 laser at 1-week interval for 10 sessions combined with narrowband and 0.05% clobetasol propionate. 
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The significant increase of pigmentation in vitiligo lesions observed with the use of fractional CO 2 laser raises interesting question on the mechanisms involved in this process. However, the exact mechanism of repigmentation is still unknown. It is well established that CO 2 resurfacing laser produces immediate tissue retraction and this shrinkage can be explained by the denaturizing of collagen bundles. 23 This shrinkage over treated skin surface may contribute to the narrowing of the vitiligo lesions . 24 In addition, melanogenic cytokines were released during inflammation and wound healing process.
This includes the release of matrix metalloproteinase-2 which stimulated melanocyte stem cells migration from adjacent normal skin, hair bulb, and outer root sheath. Therefore, we proposed that in treating vitiligo, the laser treatment must be performed over the vitiligo lesion and over a thin rim of healthy skin of about 2 mm around the lesion as a source of melanin. However, the exact mechanism of repigmentation of vitiligo Z: Z for Wilcoxon signed-rank test. *Statistically significant at P ≤ .05.
F I G U R E 5
Vitiligo section stained by Melan-A: (A) before treatment showed negative expression for Melan-A (PAP 9 400), (B) after treatment by NB-UVB showed mild expression of Melan-A (PAP 9 400), (C) after treatment by CO 2 laser plus NB-UVB showed marked expression of Melan-A (PAP 9 400) induced by fractional ablative laser combined with NB-UVB still needs further investigations.
In the current study, all of the patients experienced pain during the laser treatment, as well as burning sensation, erythema, and crustation. However, all these symptoms were relieved within a day except for the crustation, which was disappeared within a week.
While other complications as infection, scaring, koebner phenomenon, or aggravation of vitiligo lesion were not detected in this study.
Bayoumi et al 13 evaluated the effect of erbium laser dermabrasion on the outcome of combined therapy with narrowband ultraviolet B and potent topical steroids for treating nonsegmental vitiligo in resistant localization. Unlike to our study, the side effects in that study were delayed healing, pain, hypertrophic scars in two patients, poor tolerance, and the high cost, leading to the limitation of the use of erbium laser in the current practice.
Fractional laser systems bring the concept of the fractional photothermolysis theory introduced in 2004 to laser skin resurfacing.
The modality creates numerous coagulated necrotic columns or microscopic thermal injury zones which are surrounded by an intact area of spared epidermis and dermis. This technique allows for a rapid repair of laser-induced thermal injury and facilitates the skin healing process, resulting in improved safety profile compared to traditional laser resurfacing modalities. 27 In conclusion NB-UVB was effective in treating vitiligo. This efficacy was enhanced by combining it with fractional CO 2 laser. Fractional CO 2 laser exerts an additive effect in enhancing the rate and degree of repigmentation by NB-UVB in vitiligo. This combined approach to treat vitiligo appears to be safe and helps to increase the patient's compliance. It is also cost beneficial and effective in different body areas. But there were many limiting factors in this study such as it was a nonrandomized study, small number of the patients, and the follow-up period is needed to be more longer up to one year. Despite encouraging results, additional studies are required in a larger series of patients to adapt the protocol and to confirm the results.
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